Annual Report by a Canadian Issuer — Form 40-F — SEA’34
Filing Table of Contents
Document/Exhibit Description Pages Size
1: 40-F Annual Report by a Canadian Issuer HTML 767K
2: EX-99.1 Miscellaneous Exhibit HTML 46K
3: EX-99.2 Miscellaneous Exhibit HTML 46K
4: EX-99.3 Miscellaneous Exhibit HTML 43K
5: EX-99.4 Miscellaneous Exhibit HTML 43K
6: EX-99.5 Miscellaneous Exhibit HTML 3.32M
7: EX-99.6 Miscellaneous Exhibit HTML 919K
8: EX-99.7 Miscellaneous Exhibit HTML 283K
9: EX-99.8 Miscellaneous Exhibit HTML 43K
15: R1 Cover HTML 100K
16: R2 Audit Information HTML 47K
17: R3 Consolidated Statements of Financial Position HTML 148K
18: R4 Consolidated Statements of Comprehensive Loss HTML 199K
19: R5 Consolidated Statements of Changes in Equity HTML 118K
20: R6 Consolidated Statements of Changes in Equity HTML 48K
(Parenthetical)
21: R7 Consolidated Statements of Cash Flows HTML 140K
22: R8 Nature of Operations HTML 48K
23: R9 Significant Accounting Policies and Judgments HTML 71K
24: R10 Restructuring Provision HTML 69K
25: R11 Accounts Receivable HTML 55K
26: R12 Government Grant HTML 47K
27: R13 Investments HTML 70K
28: R14 Marketable Securities and Derivatives HTML 146K
29: R15 Investments in Associates and Joint Ventures HTML 74K
30: R16 Biological Assets HTML 55K
31: R17 Inventory HTML 77K
32: R18 Property, Plant and Equipment HTML 137K
33: R19 Assets and Liabilities Held for Sale and HTML 118K
Discontinued Operations
34: R20 Business Combinations HTML 68K
35: R21 Asset Acquisition and Non-controlling Interest HTML 51K
(?Nci?)
36: R22 Intangible Assets and Goodwill HTML 172K
37: R23 Convertible Debentures HTML 66K
38: R24 Share Capital HTML 99K
39: R25 Share-Based Compensation HTML 124K
40: R26 Loss Per Share HTML 54K
41: R27 Other Gains (Losses) HTML 60K
42: R28 Supplemental Cash Flow Information HTML 61K
43: R29 Income Taxes HTML 153K
44: R30 Related Party Transactions HTML 69K
45: R31 Commitments and Contingencies HTML 69K
46: R32 Revenue HTML 66K
47: R33 Segmented Information HTML 80K
48: R34 Fair Value of Financial Instruments HTML 116K
49: R35 Financial Instruments Risk HTML 88K
50: R36 Capital Management HTML 46K
51: R37 Subsequent Events HTML 46K
52: R38 Lease Liabilities HTML 62K
53: R39 Significant Accounting Policies and Judgments HTML 273K
(Policies)
54: R40 Significant Accounting Policies and Judgments HTML 52K
(Tables)
55: R41 Restructuring Provision (Tables) HTML 49K
56: R42 Accounts Receivable (Tables) HTML 52K
57: R43 Marketable Securities and Derivatives (Tables) HTML 145K
58: R44 Investments in Associates and Joint Ventures HTML 98K
(Tables)
59: R45 Biological Assets (Tables) HTML 97K
60: R46 Inventory (Tables) HTML 73K
61: R47 Property, Plant and Equipment (Tables) HTML 117K
62: R48 Assets and Liabilities Held for Sale and HTML 102K
Discontinued Operations (Tables)
63: R49 Business Combinations (Tables) HTML 59K
64: R50 Asset Acquisition and Non-controlling Interest HTML 47K
(?Nci?) (Tables)
65: R51 Intangible Assets and Goodwill (Tables) HTML 171K
66: R52 Convertible Debentures (Tables) HTML 57K
67: R53 Share Capital (Tables) HTML 91K
68: R54 Share-Based Compensation (Tables) HTML 118K
69: R55 (Loss) Earnings Per Share (Tables) HTML 52K
70: R56 Other Gains (Losses) (Tables) HTML 60K
71: R57 Supplemental Cash Flow Information (Tables) HTML 62K
72: R58 Income Taxes (Tables) HTML 150K
73: R59 Related Party Transactions (Tables) HTML 67K
74: R60 Commitments and Contingencies (Tables) HTML 47K
75: R61 Revenue (Tables) HTML 58K
76: R62 Segmented Information (Tables) HTML 77K
77: R63 Fair Value of Financial Instruments (Tables) HTML 158K
78: R64 Financial Instruments Risk (Tables) HTML 81K
79: R65 Lease Liabilities (Tables) HTML 57K
80: R66 Significant Accounting Policies and Judgments - HTML 63K
Major Subsidiaries Over Which the Company Has
Control (Details)
81: R67 Restructuring Provision - Narrative (Details) HTML 51K
82: R68 Restructuring Provision - Rollforward of HTML 49K
Restructuring Provision (Details)
83: R69 Accounts Receivable (Details) HTML 56K
84: R70 Government Grant (Details) HTML 56K
85: R71 Investments - Choom Holdings Inc. (Details) HTML 123K
86: R72 Investments - Australis Capital Inc. (Details) HTML 71K
87: R73 Investments - Radient Technologies Inc. (Details) HTML 54K
88: R74 Investments - Cann Group Limited (Details) HTML 75K
89: R75 Investments - Capcium, Inc. (Details) HTML 81K
90: R76 Investments - Investee - B (Details) HTML 92K
91: R77 Investments - High Tide Inc. (Details) HTML 155K
92: R78 Investments - Investee C (Details) HTML 64K
93: R79 Marketable Securities and Derivatives - Marketable HTML 103K
Securities (Details)
94: R80 Marketable Securities and Derivatives - Derivative HTML 107K
Investments (Details)
95: R81 Investments in Associates and Joint Ventures - HTML 77K
Summary of Carrying Value (Details)
96: R82 Biological Assets - Significant Unobservable HTML 61K
Assumptions Used in the Valuation of Biological
Assets, Including Sensitivities (Details)
97: R83 Biological Assets - Changes in Carrying Value of HTML 58K
Biological Assets (Details)
98: R84 Biological Assets - Narrative (Details) HTML 56K
99: R85 Inventory (Details) HTML 89K
100: R86 Property, Plant and Equipment - Narrative HTML 100K
(Details)
101: R87 Property, Plant and Equipment - Carrying Values of HTML 171K
Property, Plant and Equipment (Details)
102: R88 Assets and Liabilities Held for Sale and HTML 108K
Discontinued Operations - Assets Held For Sale
(Details)
103: R89 Assets and Liabilities Held for Sale and HTML 142K
Discontinued Operations - Narrative (Details)
104: R90 Assets and Liabilities Held for Sale and HTML 68K
Discontinued Operations - Discontinued Operations
(Details)
105: R91 Business Combinations - Narrative (Details) HTML 71K
106: R92 Business Combinations - Business Combinations HTML 99K
Completed (Details)
107: R93 Asset Acquisition and Non-controlling Interest HTML 57K
(?NCI?) - Net Change in Non-Controlling Interests
(Details)
108: R94 Asset Acquisition and Non-controlling Interest HTML 66K
(?NCI?) - Narrative (Details)
109: R95 Intangible Assets and Goodwill - Useful Lives HTML 54K
(Details)
110: R96 Intangible Assets and Goodwill - Continuity HTML 104K
Schedule of Intangible Assets and Goodwill
(Details)
111: R97 Intangible Assets and Goodwill - Changes in Net HTML 104K
Book Value of Intangible Assets and Goodwill
(Details)
112: R98 Intangible Assets and Goodwill - Narrative HTML 104K
(Details)
113: R99 Intangible Assets and Goodwill - Key Assumptions HTML 95K
Used in Impairment Testing (Details)
114: R100 Convertible Debentures - Activity of Convertible HTML 62K
Debentures (Details)
115: R101 Convertible Debentures - Narrative (Details) HTML 124K
116: R102 Share Capital - Narrative (Details) HTML 140K
117: R103 Share capital - Summary of Shares Issued for HTML 53K
Equity Financing (Details)
118: R104 Share Capital - Share Purchase Warrants (Details) HTML 44K
119: R105 Share Capital - Summary of Warrant Derivative HTML 57K
Liabilities (Details)
120: R106 Share Capital - Summary of Warrants Outstanding HTML 64K
(Details)
121: R107 Share-Based Compensation - Narrative (Details) HTML 80K
122: R108 Share-Based Compensation - Summary of Options HTML 71K
Outstanding (Details)
123: R109 Share-Based Compensation - Stock Options that HTML 78K
Remain Outstanding, by Exercise Price Range
(Details)
124: R110 Share-Based Compensation - Weighted Average HTML 53K
Assumptions of Options (Details)
125: R111 Share-Based Compensation - Summary of RSUs and HTML 76K
DSUs Outstanding (Details)
126: R112 Share-Based Compensation - RSUs and DSUs that HTML 65K
Remain Outstanding (Details)
127: R113 Share-Based Compensation - Summary of PSUs HTML 66K
Outstanding (Details)
128: R114 Share-Based Compensation - PSUs that Remain HTML 65K
Outstanding (Details)
129: R115 Share-Based Compensation - Weighted Average HTML 56K
Assumptions of PSUs (Details)
130: R116 (Loss) Earnings Per Share (Details) HTML 76K
131: R117 Other Gains (Losses) (Details) HTML 70K
132: R118 Supplemental Cash Flow Information - Changes in HTML 62K
Non-Cash Working Capital (Details)
133: R119 Supplemental Cash Flow Information - Supplementary HTML 54K
Cash Flow Information (Details)
134: R120 Supplemental Cash Flow Information - Narrative HTML 49K
(Details)
135: R121 Income Taxes - Narrative (Details) HTML 49K
136: R122 Income Taxes - Reconciliation of Net Tax Provision HTML 71K
to Income (Loss) Before Income Tax (Details)
137: R123 Income Taxes - Movements in Deferred Tax Assets HTML 130K
(Liabilities) (Details)
138: R124 Income Taxes - Deferred Tax Assets (Liabilities) HTML 50K
(Details)
139: R125 Income Taxes - Deferred Tax Assets Not Recognized HTML 72K
(Details)
140: R126 Related Party Transactions - Compensation Expense HTML 54K
(Details)
141: R127 Related Party Transactions - Transactions with HTML 44K
Related Parties (Details)
142: R128 Related Party Transactions - Receivable from HTML 74K
(Payable to) Related Parties (Details)
143: R129 Commitments and Contingencies - Narrative HTML 66K
(Details)
144: R130 Commitments and Contingencies - Future Commitments HTML 50K
Including Minimum Royalty Payments Due in the Next
Five Years (Details)
145: R131 Revenue - Narrative (Details) HTML 46K
146: R132 Revenue - Revenue from the Transfer of Goods and HTML 64K
Services (Details)
147: R133 Segmented Information - Operating Segments HTML 64K
(Details)
148: R134 Segmented Information - Geographical Segments HTML 57K
(Details)
149: R135 Segmented Information - Narrative (Details) HTML 53K
150: R136 Fair Value of Financial Instruments - Carrying HTML 144K
Values of Financial Instruments (Details)
151: R137 Fair Value of Financial Instruments - Summary of HTML 79K
Financial Instruments Measured at Fair Value
(Details)
152: R138 Fair Value of Financial Instruments - Continuity HTML 70K
Schedule of Contingent Consideration Payable
(Details)
153: R139 Fair Value of Financial Instruments - Narrative HTML 57K
(Details)
154: R140 Financial Instruments Risk - Credit Risk Narrative HTML 50K
(Details)
155: R141 Financial Instruments Risk - Schedule of Aging of HTML 51K
Receivables (Details)
156: R142 Financial Instruments Risk - Schedule of HTML 67K
Contractual Cash Flows from Lease Receivables
(Details)
157: R143 Financial Instruments Risk - Schedule of Accounts HTML 57K
Payable and Accrued Liabilities (Details)
158: R144 Financial Instruments Risk - Liquidity Risk HTML 51K
Narrative (Details)
159: R145 Financial Instruments Risk - Market Risk Narrative HTML 64K
(Details)
160: R146 Capital Management (Details) HTML 44K
161: R147 Subsequent Events (Details) HTML 47K
162: R148 Lease Liabilities - Lease Liabilities (Details) HTML 59K
163: R149 Lease Liabilities - Narrative (Details) HTML 44K
164: R9999 Uncategorized Items - _IXDS HTML 96K
167: XML IDEA XML File -- Filing Summary XML 318K
165: XML XBRL Instance -- acb-20220630_htm XML 6.98M
166: EXCEL IDEA Workbook of Financial Reports XLSX 407K
11: EX-101.CAL XBRL Calculations -- acb-20220630_cal XML 361K
12: EX-101.DEF XBRL Definitions -- acb-20220630_def XML 1.94M
13: EX-101.LAB XBRL Labels -- acb-20220630_lab XML 3.95M
14: EX-101.PRE XBRL Presentations -- acb-20220630_pre XML 2.64M
10: EX-101.SCH XBRL Schema -- acb-20220630 XSD 576K
168: JSON XBRL Instance as JSON Data -- MetaLinks 732± 1.14M
169: ZIP XBRL Zipped Folder -- 0001683541-22-000002-xbrl Zip 1.26M
Filing Submission 0001683541-22-000002 – SGML Text
To view the SGML, please refresh this page.
↑Top
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help —
Sun., Apr. 28, 9:31:41.2am ET 
